Population Pharmacokinetics of Amikacin in Adult Patients with Cystic Fibrosis | Zendy

Sílvia M. Illamola | Zendy; Hoa Q. Huynh | Zendy; Xiaoxi Liu | Zendy; Zubin Bhakta | Zendy; Catherine M.T. Sherwin | Zendy; Theodore G. Liou | Zendy; Holly Carveth | Zendy; David C. Young | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Population Pharmacokinetics of Amikacin in Adult Patients with Cystic Fibrosis

Author(s) -

Sílvia M. Illamola,

Hoa Q. Huynh,

Xiaoxi Liu,

Zubin Bhakta,

Catherine M.T. Sherwin,

Theodore G. Liou,

Holly Carveth,

David C. Young

Publication year - 2018

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.00877-18

Subject(s) - cystic fibrosis , pharmacokinetics , amikacin , population pharmacokinetics , medicine , population , metabolic clearance rate , pharmacology , antibiotics , intensive care medicine , biology , microbiology and biotechnology , environmental health

Practitioners commonly use amikacin in patients with cystic fibrosis. Establishment of the pharmacokinetics of amikacin in adults with cystic fibrosis may increase the efficacy and safety of therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research